Kala Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Go back to Kala Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
(NASDAQ: KALA) Delayed: 0.54 -0.02 (3.57%)
Previous Close $0.56    52 Week High
Open $0.55    52 Week Low
Day High $0.58    P/E N/A 
Day Low $0.53    EPS
Volume 81,739